United States, U.S. Drug Company Merck Announce Grant to Combat HIV/AIDS in Jamaica
June 15, 2004
On Monday, the U.S. Ambassador to Jamaica and drug firm Merck announced a $200,000 five-year grant to help pay for an HIV monitoring system and to increase awareness of the disease. Merck donated $40,000, and the U.S. Agency for International Development (USAID) will donate about $160,000 over five years, said U.S. Ambassador Sue Cobb, who was joined in Kingston by Merck and USAID representatives for the announcement. The local nongovernmental group Jamaica AIDS Support will administer the funds. New HIV/AIDS cases grew in 2003 by 8.2 percent over 2002, according to the Health Ministry, which cited no reason for the increase. HIV/AIDS is the leading cause of death for women ages 20-29 in Jamaica, according to USAID.
Jamaica Signs First Global Fund Grant Agreement That Uses Antiretroviral Drug Prices Negotiated by Clinton Foundation
This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. Visit the CDC's website to find out more about their activities, publications and services.